| Page 1643 | Kisaco Research
 

Rick Calle

Head of Business Development for AI Research
Microsoft

Rick Calle

Head of Business Development for AI Research
Microsoft

Rick Calle

Head of Business Development for AI Research
Microsoft
 

Mark O’Connor

Director of Deep Learning
Arm

Mark O’Connor

Director of Deep Learning
Arm

Mark O’Connor

Director of Deep Learning
Arm
 

Mahesh Makhijani

VP Business Development
GrAIMatter Labs

Mahesh Makhijani

VP Business Development
GrAIMatter Labs

Mahesh Makhijani

VP Business Development
GrAIMatter Labs
 

Ingo Thon

Principal Key Expert Artificial Intelligence
Siemens

Ingo Thon

Principal Key Expert Artificial Intelligence
Siemens

Ingo Thon

Principal Key Expert Artificial Intelligence
Siemens
Innovation Showcase Finalists 2020
The Digitisation of Pet Care with David Hallas
 
CLEAN BEAUTY CONNECT 2021
28-29 Jun 2021
VIRTUAL SUMMIT | PDT Timezone
Clean Beauty Connect is the leading network driving innovation in beauty and personal care towards a cleaner, more transparent industry. This summit provides the platform for brands to collaborate with innovation leaders, uniting the industry in its sustainability mission.The market value of clean beauty is expected to grow by $20 billion dollars before 2027 and the onset of the pandemic has made health and safety paramount, with clean formulations becoming table stakes.However, safety of ingredients is no longer enough for the conscious consumer with 60% looking to buy from socially and environmentally responsible companies. In such a fast-evolving industry, it is imperative brands meet those demands to gain the competitive edge.We are the established platform bringing together brands and innovation leaders to share their expertise and allow you to meet your sustainability goals. Join this event to gain the knowledge and connections to ensure your company’s next step in becoming clean in 2021.
 

Oliver Boucher

Senior Director
Zoetis

Oliver Boucher has a successful track record creating and managing start-ups and executing strategic transactions at Board level on both the buy-side and sell-side of the life science business-to-business (B2B) market within the pharmaceutical and diagnostics industries. He also has significant experience in fund-raising, both dilutive and non-dilutive. He has held senior commercial and business roles in a succession of biotech companies after having gained executive level experience for seven years as a director of business development at GSK.

Oliver Boucher

Senior Director
Zoetis

Oliver Boucher

Senior Director
Zoetis

Oliver Boucher has a successful track record creating and managing start-ups and executing strategic transactions at Board level on both the buy-side and sell-side of the life science business-to-business (B2B) market within the pharmaceutical and diagnostics industries. He also has significant experience in fund-raising, both dilutive and non-dilutive. He has held senior commercial and business roles in a succession of biotech companies after having gained executive level experience for seven years as a director of business development at GSK. Before joining industry, Oliver Boucher was a patent attorney in London, Montreal and Paris. He received an MA in genetics and molecular biology from Cambridge University and earned an MBA from INSEAD Business School. Mr Boucher joined Zoetis in 2017.

Systems-level considerations for AI Hardware: Perspectives from DeepMind & Flex Logix
In Conversation with Roy Stein, BabelBark